Cargando…
The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome
Arginine vasopressin (AVP) was suggested to contribute to cardiovascular risk and type 2 diabetes in patients with metabolic syndrome. The proinflammatory cytokine interleukin (IL)-1 is able to induce AVP secretion and plays a causal role in cardiovascular mortality and type 2 diabetes. We investiga...
Autores principales: | Popovic, Milica, Ebrahimi, Fahim, Urwyler, Sandrine Andrea, Donath, Marc Yves, Christ-Crain, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424357/ https://www.ncbi.nlm.nih.gov/pubmed/32698151 http://dx.doi.org/10.1530/EC-20-0197 |
Ejemplares similares
-
Exercise upregulates copeptin levels which is not regulated by interleukin-1
por: Popovic, Milica, et al.
Publicado: (2019) -
Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
por: Ebrahimi, Fahim, et al.
Publicado: (2021) -
Copeptin is not useful as a marker of malignant disease in the syndrome of inappropriate antidiuresis
por: Winzeler, Bettina, et al.
Publicado: (2019) -
SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019) -
Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis
por: Refardt, Julie, et al.
Publicado: (2019)